December 7, 2016 / 8:07 PM / in 10 months

BRIEF-Merck Canada says Zostavax II showed vaccine effectiveness against shingles in observational effectiveness study

Dec 7 (Reuters) - Merck Canada:

* New data from the largest ongoing observational study assessing shingles vaccine effectiveness presented at canadian immunization conference

* As for secondary endpoint, data showed zostavax II had 68.7 percent overall effectiveness against PHN in study

* In the observational effectiveness study, Zostavax II showed vaccine effectiveness against shingles Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below